What You Should Know:
– VieCure has raised $43M led by Mitch Rales (co-founder of Danaher) and Northpond Ventures. The funding will scale VieCure’s Halo Intelligence™ platform, an AI-powered clinical decision support system that has…
Continue Reading
Image Credit: SimonMed
What You Should Know:
– SimonMed Imaging, one of the largest outpatient medical imaging providers and radiology practices in the United States, today announced the launch of Ultrasound+, an AI-enabled ultrasound program.
– The…
Continue Reading
What You Should Know:
– Daymark Health, a company dedicated to redefining the cancer care experience secures $20M in Series A funding round led by Healthier Capital and Blue Venture Fund, with continued participation from…
Continue Reading
What You Should Know:
– Reimagine Care, the nation’s leading provider of on-demand cancer care, today announced a pilot collaboration with MedStar Health, the largest healthcare provider in Maryland and the Washington, D.C., region.
– MedStar Health…
Continue Reading
What You Should Know:
– Flatiron Health, a healthtech company focused on revolutionizing clinical research through technology integration, has announced a collaboration with NRG Oncology, a clinical research consortium within the National Cancer Institute’s (NCI)…
Continue Reading
What You Should Know:
– Frederick Health (Frederick, MD) recently launched a first-of-its-kind precision medicine integration that enhances their decision support capabilities with intuitive recommendations that are tailored to the individual patient and their cancer’s specific…
Continue Reading
What You Should Know:
– Oatmeal Health, an innovator in AI-driven cancer screening launches its AI-powered radiology risk stratification platform for lung cancer.
– The solution provides a fully reimbursable second-opinion diagnostic tool covered by Medicare,…
Continue Reading
What You Should Know:
– C the Signs, a developer of AI-powered cancer detection solutions, today announced an $8 million funding round led by Khosla Ventures.
– The investment will fuel the company’s expansion from the…
Continue Reading
What You Should Know:
– OneCell Diagnostics, a genomics-based precision oncology company, announced today that it has raised $16M in an oversubscribed Series A funding round led by Celesta Capital, with participation from Tenacity Ventures, Cedars…
Continue Reading
What You Should Know:
– PreciseDx, a pioneering company in oncology diagnostics utilizing artificial intelligence (AI) raises $20.7M in Series B funding led by Eventide Asset Management with participation from Labcorp, Quest Diagnostics, GenHenn Capital…
Continue Reading
